Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	6.17T -14.8%
Revenue (ttm)	2.40T +15.1%
Net Income	53.66B -25.2%
EPS	645.11 -18.6%
Shares Out	90.57M
PE Ratio	105.56
Forward PE	n/a
Dividend	909.09 (1.33%)
Ex-Dividend Date	n/a

Volume	6,400
Average Volume	5,921
Open	67,200
Previous Close	68,100
Day's Range	67,000 - 68,100
52-Week Range	66,200 - 86,800
Beta	0.22
RSI	42.79
Earnings Date	May 8, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, pharmaceutical chemicals, cosmetics and medical equipment. The company provides medical material, medicinal foods, and hygiene products. It also engages in the real estate business, land use rights owned, used or leased business. In addition, the company produces and sell functional foods; and manufacturing to order; and import-export authorization services, as well as trading of raw materials. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 586
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2025, Ha Tay Pharmaceutical JSC's revenue was 2.40 trillion, an increase of 15.13% compared to the previous year's 2.09 trillion. Earnings were 53.66 billion, a decrease of -25.24%.